About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Liver Cancer Diagnostics Market Size, Top Share, Forecast to 2031
Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54724DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Liver Cancer Diagnostics Market Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Laboratory Tests
        1. By Value
      3. Imaging
        1. By Value
      4. Endoscopy
        1. By Value
      5. Biopsy
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Laboratory Tests
        1. By Value
      3. Imaging
        1. By Value
      4. Endoscopy
        1. By Value
      5. Biopsy
        1. By Value
      6. Others
        1. By Value
    3. U.S.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Laboratory Tests
          1. By Value
        3. Imaging
          1. By Value
        4. Endoscopy
          1. By Value
        5. Biopsy
          1. By Value
        6. Others
          1. By Value
    4. Canada
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Laboratory Tests
        1. By Value
      3. Imaging
        1. By Value
      4. Endoscopy
        1. By Value
      5. Biopsy
        1. By Value
      6. Others
        1. By Value
    3. U.K.
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Laboratory Tests
          1. By Value
        3. Imaging
          1. By Value
        4. Endoscopy
          1. By Value
        5. Biopsy
          1. By Value
        6. Others
          1. By Value
    4. Germany
    5. France
    6. Spain
    7. Italy
    8. Russia
    9. Nordic
    10. Benelux
    11. Rest of Europe
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Laboratory Tests
        1. By Value
      3. Imaging
        1. By Value
      4. Endoscopy
        1. By Value
      5. Biopsy
        1. By Value
      6. Others
        1. By Value
    3. China
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Laboratory Tests
          1. By Value
        3. Imaging
          1. By Value
        4. Endoscopy
          1. By Value
        5. Biopsy
          1. By Value
        6. Others
          1. By Value
    4. Korea
    5. Japan
    6. India
    7. Australia
    8. Taiwan
    9. South East Asia
    10. Rest of Asia-Pacific
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Laboratory Tests
        1. By Value
      3. Imaging
        1. By Value
      4. Endoscopy
        1. By Value
      5. Biopsy
        1. By Value
      6. Others
        1. By Value
    3. UAE
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Laboratory Tests
          1. By Value
        3. Imaging
          1. By Value
        4. Endoscopy
          1. By Value
        5. Biopsy
          1. By Value
        6. Others
          1. By Value
    4. Turkey
    5. Saudi Arabia
    6. South Africa
    7. Egypt
    8. Nigeria
    9. Rest of MEA
    1. Introduction
    2. By Test Type
      1. Introduction
        1. Test Type By Value
      2. Laboratory Tests
        1. By Value
      3. Imaging
        1. By Value
      4. Endoscopy
        1. By Value
      5. Biopsy
        1. By Value
      6. Others
        1. By Value
    3. Brazil
      1. By Test Type
        1. Introduction
          1. Test Type By Value
        2. Laboratory Tests
          1. By Value
        3. Imaging
          1. By Value
        4. Endoscopy
          1. By Value
        5. Biopsy
          1. By Value
        6. Others
          1. By Value
    4. Mexico
    5. Argentina
    6. Chile
    7. Colombia
    8. Rest of LATAM
    1. Liver Cancer Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. F. Hoffmann-La Roche Ltd.
    3. Qiagen N.V.
    4. Thermo Fisher Scientific, Inc.
    5. Siemens Healthineers
    6. Becton Dickinson & Company
    7. Illumina, Inc.
    8. Epigenomics AG
    9. Koninklijke Philips N.V.
    10. Fujifilm Medical Systems U.S.A., Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Cancer Diagnostics Market Size The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 billion in 2025 to USD 178.26 billion by 2033, growing at a CAGR of 5.91% during the forecast
Buy Now
Global Report
Clinical Diagnostics Market Size The global clinical diagnostics market size was valued at USD 84.18 billion in 2024 and is projected to reach from USD 98.21 billion in 2025 to USD 187.78 billion by 2033, exhibiting a CAGR of 6.48% during the f
Buy Now
Global Report
Molecular Diagnostics Market Size & Trends The global molecular diagnostics market size was valued at USD 14.93 billion in 2023 and is projected to reach USD 33.40 billion by 2032, growing at a CAGR of 9.36% during the forecast period (2024–2032).
Buy Now
Global Report
The global paper diagnostics market size was valued at USD 8 billion in 2021, and it is anticipated to reach USD 16.17 billion by 2030 at a CAGR of 8.13%. Paper diagnostics are a series of diagnostic procedures that can be carried out with inexpensi
Buy Now
Global Report
Point of Care Diagnostics Market Size The global point of care diagnostics market size was valued at USD 44.09 billion in 2023 and is projected to reach USD 78.83 billion by 2032, growing at a CAGR of 6.67% during the forecast pe
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.